The conventional egg cycle remains deeply unfavorable with no near-term catalyst for rebalancing. The company's shift toward Specialty and Prepared Foods (now 54% of sales) provides some earnings diversification but not enough to offset the commodity downturn. Monitor weekly egg price data and the timing of Prepared Foods capacity expansion (60%+ by H1 FY2028) for signs of earnings recovery.
Price Chart
Executive Summary
Cal-Maine Foods reported a massive earnings miss for Q1 FY2027, with EPS of -$1.26 versus consensus of -$0.76 (65.8% miss) and revenue of $539.6M versus $561.6M consensus (3.9% miss). The miss was driven by a 41.5% YoY revenue decline and near-zero gross profit ($0.4M vs $311.3M), as conventional shell egg prices collapsed 59.3% amid industry oversupply. No dividend will be paid due to a cumulative loss of $94.5M, and the company's outlook commentary offered no concrete guidance for a near-term recovery.
Key Financial Metrics
Key Facts
- EPS of -$1.26 missed consensus of -$0.76 by 65.8%
- Revenue of $539.6M missed consensus of $561.6M by 3.9% and declined 41.5% YoY from $922.6M
- Gross profit collapsed to $0.4M from $311.3M YoY (99.9% decline)
- Operating loss of $82.2M vs operating income of $249.2M YoY
- Conventional Shell Eggs segment swung from $168.2M profit to $71.0M loss as average selling price per dozen fell 59.3%
- No dividend declared for Q1; cumulative loss of $94.5M must be recovered before future dividends
- Company repurchased 66,601 shares for $5.0M in Q1 and an additional 204,888 shares for $14.9M after quarter-end
- Prepared Foods sales fell 13.0% due to temporary production reductions during capacity expansion
Financial Impact
EPS miss of $0.50 vs consensus; revenue miss of $22M; gross profit nearly eliminated at $0.4M vs $311.3M YoY
Risk Factors
- Prolonged conventional egg price weakness due to industry oversupply
- Cumulative loss of $94.5M prevents dividend payments until profitability is restored
- Prepared Foods production disruptions during capacity expansion may continue to weigh on segment results
- Avian flu (HPAI) outbreak risk could further disrupt supply or demand
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3371667 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | Institutional Cluster | $63.83 $62.60 | ▲ +1.93% | ▲ +1.40% | $61.41 (+3.79%) |
Oct 8, 2026 18d ago | SC 13G/A | $64.83 $64.35 | ▲ +0.74% | ▲ +1.34% | $61.41 (+5.28%) |
Sep 30, 2026 27d ago | 8-K | $68.06 $65.84 | ▲ +3.26% | ▲ +3.44% | $61.41 (+9.77%) |
Sep 30, 2026 27d ago | Press Release | $68.06 $65.84 | ▲ +3.26% | ▲ +3.44% | $61.41 (+9.77%) |
Sep 9, 2026 6w ago | Press Release | $73.71 | awaiting T+1 | — | $61.41 (−16.69%) |
Jul 22, 2026 13w ago | 8-K | $87.86 $88.14 | ▼ −0.32% | ▼ −1.55% | $61.41 (+30.10%) |
Jul 6, 2026 16w ago | Press Release | $85.41 $85.08 | ▼ −0.39% | ▼ −0.08% | $61.41 (−28.10%) |
Jun 23, 2026 17w ago | 8-K | $79.03 $78.24 | ▼ −0.99% | ▼ −1.14% | $61.41 (−22.29%) |
May 12, 2026 24w ago | Press Release | $78.88 $79.51 | ▲ +0.80% | ▲ +0.22% | $61.41 (−22.15%) |
Apr 1, 2026 29w ago | 8-K | $82.98 $78.10 | ▼ −5.88% | ▼ −5.96% | $61.41 (−25.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers